Grant: Catalyst Grant: Human Microbiome
University of British Columbia
$100,000.00
Linking Infectious Agents to Cancer: A Metagenomics Approach
EF 2008-09
Résumé
Infectious agents including viruses and bacteria are known causes of greater than 20% of cancer cases worldwide. There are likely further infectious agent causes of cancer that are yet to be discovered, involving both known and unknown pathogens. We propose to analyse the whole transcriptome of two tumour types in a small number of patients using the ultra high throughput sequencing and analysis. These two tumour types have been chosen because of their suggested yet still unproven association with infectious agents. This methodology, once validated, can be applied to many tumour types and will yield important data on the infectious causes of cancer. This information can then be used for cancer treatment and prevention by targeting the cancer causing agents themselves.
Programme
Catalyst Grant: Human Microbiome
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
172981
Name
Holt Rob
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
Linking Infectious Agents to Cancer: A Metagenomics Approach
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
Carcinogenic Viruses; Gene Expression Analysis; Infectious Agents; Metagenomics; Whole Transcriptome Shotgun Sequencing (Wtss)
Abstract
Infectious agents including viruses and bacteria are known causes of greater than 20% of cancer cases worldwide. There are likely further infectious agent causes of cancer that are yet to be discovered, involving both known and unknown pathogens. We propose to analyse the whole transcriptome of two tumour types in a small number of patients using the ultra high throughput sequencing and analysis. These two tumour types have been chosen because of their suggested yet still unproven association with infectious agents. This methodology, once validated, can be applied to many tumour types and will yield important data on the infectious causes of cancer. This information can then be used for cancer treatment and prevention by targeting the cancer causing agents themselves.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Holt, Rob
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Infection & Immunity~ $100,000~ $0~